Skip to main content
Livermore
Livermore
ZHEN

Barclays PLC

SEC CIK
0000312069
Latest filing
Aug 14, 2026

ALDX holding history

Aldeyra Therapeutics, Inc. in every 13F filed by Barclays PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALDX overviewAll 13F holders of ALDXFull Q2 2026 holdings

Shares (Q2 2026)
5,769
Value
$12.3K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of ALDX by Barclays PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,769$12.3K<0.1%−4,137−41.8%ReducedHolders
Q1 20269,906$16.7K<0.1%−74,565−88.3%ReducedHolders
Q4 202584,471$437.6K<0.1%+7,827+10.2%AddedHolders
Q3 202576,644$400.1K<0.1%−19,004−19.9%ReducedHolders
Q2 202595,648$366.3K<0.1%+44,691+87.7%AddedHolders
Q1 202550,957$293.0K<0.1%−24,373−32.4%ReducedHolders
Q4 202475,330$375.9K<0.1%+9,769+14.9%AddedHolders
Q3 202465,561$353.4K<0.1%+48,313+280.1%AddedHolders
Q2 202417,248$57.1K<0.1%−15,239−46.9%ReducedHolders
Q1 202432,487$106.2K<0.1%−31,368−49.1%ReducedHolders
Q4 202363,855$224.1K<0.1%−74,456−53.8%ReducedHolders
Q3 2023138,311$923.9K<0.1%+11,447+9.0%AddedHolders
Q2 2023126,864$1.06M<0.1%+110,039+654.0%AddedHolders
Q1 202316,825$167.1K<0.1%−12,954−43.5%ReducedHolders
Q4 202229,779$207.3K<0.1%+20,844+233.3%AddedHolders
Q3 20228,935$48.0K<0.1%+8,935NewHolders
Q2 20220$00.0%−150,981−100.0%Sold outHolders
Q1 2022150,981$671.0K<0.1%+92,072+156.3%AddedHolders
Q4 202158,909$236.0K<0.1%+15,028+34.2%AddedHolders
Q3 202143,881$386.0K<0.1%+15,186+52.9%AddedHolders
Q2 202128,695$325.0K<0.1%−22,050−43.5%ReducedHolders
Q1 202150,745$603.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.